Adjustment of OMXC20 index due to the stock split in Novo Nordisk


Due to the Split 2:1, in Novo Nordisk A/S (NOVO B, DK0010280817), OMX
Derivatives Markets will act and adjust NOVO B in accordance to the “Guidelines
for Calculation of the OMXC20 Index”, rule 5.2. 

On the ex-day December 3, 2007 the number of shares for NOVO B in OMXC20 index
will be increased to 566 432 800 shares. 


For further information concerning this exchange notice please contact Ida
Gustavsson or Erik Hågemo, telephone +46 8 405 60 00 

OMX Derivatives Markets
	
Ida Gustavsson	Erik Hågemo
Index Manager	Junior Index Analyst